Veravas, a leader in clinical diagnostics, today announced the general commercial availability of VeraBIND™ Tau, the first blood-based test designed to aid in the detection of Alzheimer's disease (AD) ...

Sequential testing, they think, would work best to screen candidates for clinical trials. Plasma p-tau217 and tau-PET imaging both predict cognitive decline. In cognitively normal people, the two ...

See α-Synuclein. Candidate tracer SY08 detects α-synuclein deposits in the brainstem (right) and parietal cortex (left) of ...

FDG-PET imaging is not routinely employed in this type of cancer and its role in endometrial cancer is still being studied and yet to be defined. In a series of 41 whole-body PET studies conducted ...

ARUP Laboratories has introduced a blood test for phosphorylated tau 217 (pTau 217) to aid in diagnosing the pathology of ...

A novel PET imaging approach can effectively quantify a key enzyme associated with brain inflammation, according to research published in the March issue of The Journal of Nuclear Medicine.

This collaboration will focus on demonstrating the value of 4R Tau PET imaging biomarkers in advancing our understanding of CTE. The initial aspects of the CTE partnership will involve ...

This collaboration will focus on demonstrating the value of 4R Tau PET imaging biomarkers in advancing our understanding of CTE. The initial aspects of the CTE partnership will involve ...

PET imaging shows that the brain increases dopamine production when completing cognitively demanding tasks, and that the more dopamine released, the more efficiently the tasks are completed.